InvestorsHub Logo
Followers 163
Posts 12871
Boards Moderated 1
Alias Born 01/26/2016

Re: Doc logic post# 59742

Tuesday, 04/26/2016 12:47:03 PM

Tuesday, April 26, 2016 12:47:03 PM

Post# of 698586
flipper44,

I forgot to mention that with proneural those older targets are basically still the same and they are protected from an immune response much better which is why the checkpoint inhibitors are needed. If at crossover patients are also receiving checkpoint inhibitors we have a secondary endpoint issue because all patients might be living longer right? Maybe that is why there has been talk about collaborations?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News